Tina Larson
President presso RECURSION PHARMACEUTICALS, INC.
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
Attualmente, Tina Larson occupa la posizione di presidente e direttore operativo di Recursion Pharmaceuticals, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/03/2024 | 639 982 ( 0.31% ) | 6 M $ | 31/03/2024 |
Posizioni attive di Tina Larson
| Società | Posizione | Inizio |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | President | 01/10/2019 |
Revagenix , Inc.
 Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Chairman | - |
Precedenti posizioni note di Tina Larson
| Società | Posizione | Fine |
|---|---|---|
| ACHAOGEN | Corporate Officer/Principal | 01/06/2018 |
| Roche, Inc. | Corporate Officer/Principal | 01/04/2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di Tina Larson
| Colorado State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche, Inc. | |
Revagenix , Inc.
Revagenix , Inc. BiotechnologyHealth Technology Revagenix, Inc. engages in the research and development of antibiotics. The company is based in San Mateo, CA. The company was founded in 2019 by Ryan Cirz and Andrew McCandlish. Ryan Cirz has been the CEO since 2019. | Health Technology |
- Borsa valori
- Insiders
- Tina Larson
